Effects of Continuous Glucose Monitoring Versus Blood Glucose Monitoring During a Carbohydrate-Restricted Nutrition Intervention in People With Type 2 Diabetes: 6-Month Follow-up Outcomes From a Randomized Clinical Trial
The CGM and BGM arms achieved similar and significant improvements in glycemia and other diabetes-related outcomes after 6 months in this MSKDP.
Authors
- Shaminie J. Athinarayanan (ORCID: https://orcid.org/0000-0001-5427-6748)
- Rebecca N. Adams (ORCID: https://orcid.org/0000-0002-2715-649X)
- Stephen E. Asche (ORCID: https://orcid.org/0000-0002-8355-6500)
- Richard M. Bergenstal (ORCID: https://orcid.org/0000-0002-9050-5584)
- Amy L. McKenzie (ORCID: https://orcid.org/0000-0003-4549-5177)
- Holly Willis (ORCID: https://orcid.org/0000-0002-2404-5751)
- Brittanie M. Volk (ORCID: https://orcid.org/0000-0003-3530-519X)
- Shannon Krizka
- Alison R. Zoller
- CAROLINE G.P. ROBERTS (ORCID: https://orcid.org/0000-0001-7846-9800)
Institutions
- HealthPartners (US)
Publication Details
- Journal
- Endocrine Practice
- Published
- 2025-06-02
- DOI
- https://doi.org/10.1016/j.eprac.2025.05.746
- Citations
- 2
- Primary Topic
- Diet and metabolism studies
- Type
- article
- Field-Weighted Citation Impact
- 2.33
Funders
- Foundation for Advancement of Chiropractic Education
- Eli Lilly and Company
- Sanofi
- McGill University
- Insulet Corporation
- Dexcom
- Novo Nordisk
- Abbott Diabetes Care